China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
China Traditional Chinese Medicine Holdings Co Ltd
Accrued Liabilities
China Traditional Chinese Medicine Holdings Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
Accrued Liabilities
$661.1k
|
CAGR 3-Years
6%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Accrued Liabilities
HK$57.8m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Accrued Liabilities
$190.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
China Traditional Chinese Medicine Holdings Co Ltd
Glance View
China Traditional Chinese Medicine Holdings Co Ltd sits at the crossroads of ancient wisdom and modern commerce. Rooted deeply in the rich heritage of Traditional Chinese Medicine (TCM), this company skillfully crafts a range of products that cater to both domestic and international markets. At the core of its operations is the cultivation and processing of Chinese medicinal herbs, which are transformed into a wide portfolio of products, including ready-to-use TCM formula granules, patented medicines, and healthcare products. By leveraging its extensive network of cultivation bases, the company ensures the authenticity and quality of its raw materials, an essential component in a sector where the efficacy of products is deeply entwined with their origins. The company’s business model thrives on vertical integration, which allows it to exercise control over the entire supply chain—from the sourcing of raw materials to the manufacturing and distribution processes. Through this multifaceted approach, China Traditional Chinese Medicine Holdings Co Ltd maximizes its profit margins while maintaining stringent quality standards, crucial in a market where consumer trust is paramount. The firm's robust distribution network spans pharmacies, hospitals, and retail outlets, supplemented by a growing e-commerce presence. As healthcare trends increasingly lean towards natural and holistic remedies around the globe, the company finds itself well-positioned to not only cater to traditional markets but also to explore new opportunities in alternative medicine sectors worldwide.